Indeed, a recent report elegantly demonstrated the distinct accumulation of activated IFN-γ overexpressing CD103+ CD69+ CD8+ TRM cells in the colon of patients who developed ICI-induced colitis following either anti-CTLA-4/PD-1 combination therapy or anti-PD-1 inhibitor therapy. The gene discussed is IFNG; the disease is colitis.